ATE133337T1 - Behandlung des glaukoms mit synergistischer kombination - Google Patents

Behandlung des glaukoms mit synergistischer kombination

Info

Publication number
ATE133337T1
ATE133337T1 AT93307748T AT93307748T ATE133337T1 AT E133337 T1 ATE133337 T1 AT E133337T1 AT 93307748 T AT93307748 T AT 93307748T AT 93307748 T AT93307748 T AT 93307748T AT E133337 T1 ATE133337 T1 AT E133337T1
Authority
AT
Austria
Prior art keywords
treatment
synergistic combination
glaucoma
ocular
hypertension
Prior art date
Application number
AT93307748T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE133337T1 publication Critical patent/ATE133337T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93307748T 1992-10-01 1993-09-29 Behandlung des glaukoms mit synergistischer kombination ATE133337T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4284956A JPH06107547A (ja) 1992-10-01 1992-10-01 眼科用組成物

Publications (1)

Publication Number Publication Date
ATE133337T1 true ATE133337T1 (de) 1996-02-15

Family

ID=17685259

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93307748T ATE133337T1 (de) 1992-10-01 1993-09-29 Behandlung des glaukoms mit synergistischer kombination

Country Status (5)

Country Link
US (1) US5405846A (de)
EP (1) EP0590972B1 (de)
JP (1) JPH06107547A (de)
AT (1) ATE133337T1 (de)
DE (1) DE69301387T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
US5710165A (en) * 1994-07-06 1998-01-20 Synthelabo Use of polyamine antagonists for the treatment of glaucoma
US5767153A (en) * 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
EP2127638A1 (de) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
RU2624534C2 (ru) 2010-07-29 2017-07-04 Аллерган, Инк. Растворы биматопроста и тимолола, не содержащие консервантов

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
EP0286903B2 (de) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes
ES2069881T3 (es) * 1990-03-08 1995-05-16 Shionogi & Co Derivado de 15-desoxiprostaglandina.
US5166175A (en) * 1990-05-22 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of ocular hypertension with a synergistic combination
ATE207360T1 (de) * 1992-03-19 2001-11-15 R Tech Ueno Ltd Behandlung von augenhochdruck mit betablockern und prostansäurederivaten
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物

Also Published As

Publication number Publication date
EP0590972A1 (de) 1994-04-06
DE69301387T2 (de) 1996-07-25
DE69301387D1 (de) 1996-03-07
US5405846A (en) 1995-04-11
EP0590972B1 (de) 1996-01-24
JPH06107547A (ja) 1994-04-19

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DK0561073T3 (da) Behandling af øjenhypertension
CA2019974A1 (en) Treatment of inflammation
DE69719931D1 (de) Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ES2069823T3 (es) Tratamiento de la hipertension ocular con una combinacion sinergica ocular.
DE69301387D1 (de) Behandlung des Glaukoms mit synergistischer Kombination
ES2084771T3 (es) Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
IT8349538A0 (it) Esteri di derivati 3-(3-sostituitoammino-2-idrossi-propossi)-4-sostituito-1,2,5-tiadiazolici utili come agenti bloccanti beta-adrenergici eper il trattamento del glaucoma
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
DE69123892D1 (de) Behandlung von Katarakt mit prostacyclinverbindungen
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
AU7141591A (en) Treatment of ocular hypertension with class i calcium channel blocking agents
MX9207546A (es) Aminoesteroides para uso oftalmico
ITMI910845A1 (it) Preparazioni oftalmiche per il trattamento del glaucoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties